Anissa Abi-dargham M.D

Dr. Abi-Dargham's research focus is on using molecular imaging techniques to study the pathophysiology of schizophrenia, schizophrenia-related spectrum disorders, and addiction. Her work has resulted in seminal publications describing the complex alterations of dopamine transmission in schizophrenia and their relationship to clinical symptoms, cognition, and response to treatment, as well as their interrelatedness to glutamate dysfunction in schizophrenia. These studies showed increased striatal dopamine release in schizophrenia, which has become one of the most established findings of schizophrenia research and is now being tested as a biomarker for risk to develop schizophrenia in prodromal patients.